{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:11Z","timestamp":1792806011808,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["23408"],"award-info":[{"award-number":["23408"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG2019"],"award-info":[{"award-number":["IG2019"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jhepr.2023.100910","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:32:39Z","timestamp":1694759559000},"page":"100910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-6855","authenticated-orcid":false,"given":"Michela Anna","family":"Polidoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-0596","authenticated-orcid":false,"given":"Erika","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Soldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Saladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3805-4209","authenticated-orcid":false,"given":"Arianna","family":"Rosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8228-6441","authenticated-orcid":false,"given":"Andrea","family":"Mainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D\u2019Autilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3986-8790","authenticated-orcid":false,"given":"Guido","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Donadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Torzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-2635","authenticated-orcid":false,"given":"Simona","family":"Marzorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-8652","authenticated-orcid":false,"given":"Marco","family":"Rasponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-7902","authenticated-orcid":false,"given":"Ana","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100910_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100910_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100910_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma \u2013 novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jhepr.2023.100910_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/cco.2019.08.09","article-title":"Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy","volume":"9","author":"Turgeon","year":"2020","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.jhepr.2023.100910_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41575-022-00739-y","article-title":"Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance","volume":"20","author":"Calvisi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100910_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ccell.2021.05.010","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2023.100910_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100910_bib8","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0137","article-title":"Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment","volume":"14","author":"Tsai","year":"2017","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.jhepr.2023.100910_bib9","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/or.2015.3767","article-title":"Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer","volume":"33","author":"Imamura","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhepr.2023.100910_bib10","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1038\/s41598-022-11641-7","article-title":"Modelling liver cancer\u00a0microenvironment using a novel 3D culture system","volume":"12","author":"Al Hrout","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100910_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41551-020-00621-9","article-title":"A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma","volume":"5","author":"Wong","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jhepr.2023.100910_bib12","doi-asserted-by":"crossref","first-page":"L526","DOI":"10.1152\/ajplung.00153.2021","article-title":"Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures","volume":"322","author":"van Riet","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jhepr.2023.100910_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1872-2040(19)61214-4","article-title":"Study on drug resistance to tumor cell in oxygen gradient and co-culture microfluidic chip","volume":"48","author":"Sun","year":"2020","journal-title":"Chin J Anal Chem"},{"key":"10.1016\/j.jhepr.2023.100910_bib14","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/liv.14942","article-title":"Experimental liver models: from cell culture techniques to microfluidic organs-on-chip","volume":"41","author":"Polidoro","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100910_bib15","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1039\/D1BM00210D","article-title":"A 3D pancreatic tumor model to study T cell infiltration","volume":"9","author":"Mollica","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jhepr.2023.100910_bib16","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3892\/or.2016.4581","article-title":"Spheroid-based 3-dimensional culture models: gene expression and functionality in head and neck cancer","volume":"35","author":"Schmidt","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhepr.2023.100910_bib17","doi-asserted-by":"crossref","first-page":"C556","DOI":"10.1152\/ajpcell.00096.2017","article-title":"Detachment-induced E-cadherin expression promotes 3D tumor spheroid formation but inhibits tumor formation and metastasis of lung cancer cells","volume":"313","author":"Powan","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jhepr.2023.100910_bib18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.bbadis.2017.07.028","article-title":"The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma","volume":"1864","author":"Cadamuro","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhepr.2023.100910_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-4598-9-13","article-title":"Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker","volume":"9","author":"Utispan","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jhepr.2023.100910_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-017-3353-2","article-title":"Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients","volume":"80","author":"Kim","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jhepr.2023.100910_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2023.100910_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12935-019-0733-1","article-title":"The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer","volume":"19","author":"Melissaridou","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jhepr.2023.100910_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrc.2020.08.075","article-title":"Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines","volume":"533","author":"Muguruma","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2023.100910_bib24","doi-asserted-by":"crossref","first-page":"17206","DOI":"10.18632\/oncotarget.4043","article-title":"YAP is a critical oncogene in human cholangiocarcinoma","volume":"6","author":"Pei","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2023.100910_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13046-022-02394-2","article-title":"The Hippo pathway effector TAZ\u00a0induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease","volume":"41","author":"Cigliano","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jhepr.2023.100910_bib26","first-page":"22","article-title":"A microfluidic 3D endothelium-on-a-chip model to study transendothelial migration of T cells in health and disease","author":"de Haan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2023.100910_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation \u2013 a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jhepr.2023.100910_bib28","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3390\/cancers12082215","article-title":"Role of chemokines in the biology of cholangiocarcinoma","volume":"12","author":"Caligiuri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2023.100910_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4254\/wjh.v9.i9.455","article-title":"Tumor reactive stroma in cholangiocarcinoma: the fuel behind cancer aggressiveness","volume":"9","author":"Brivio","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100910_bib30","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jhep.2022.05.043","article-title":"Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target","volume":"77","author":"Alvisi","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100910_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100910_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-017-3709-3","article-title":"Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform","volume":"17","author":"Lanz","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2023.100910_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.celrep.2017.09.043","article-title":"Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro","volume":"21","author":"Hassell","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2023.100910_bib34","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1039\/C8LC00852C","article-title":"Development of a biomimetic liver tumor-on-a-chip model based on decellularized liver matrix for toxicity testing","volume":"18","author":"Lu","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.jhepr.2023.100910_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.memsci.2007.07.002","article-title":"Preparation and oxygen\/nitrogen permeability of PDMS crosslinked membrane and PDMS\/tetraethoxysilicone hybrid membrane","volume":"303","author":"Rao","year":"2007","journal-title":"J\u00a0Memb Sci"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:58:28Z","timestamp":1716271108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923002410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2589555923002410"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100910","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100910"}}